Indiana University
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Indiana University sits in the top decile of US sponsors by registered trial count (#38 of 15,742 sponsors by registered trial count).
Indiana University: 890 sponsored US clinical trials, 156 recruiting.
Indiana University sponsors 890 registered US clinical trials on ClinicalTrials.gov, 156 of them currently recruiting, and 561 completed. 104 of these trials are in Phase 3-4 (later-stage) and 126 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Alzheimer Disease, with 11 trials.
Top-decile sponsor footprint
Indiana University ranks in the top decile of sponsors by registered trial count (#38 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
561 of 688 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (81.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
890 total, page 14 of 18
Efavirenz Versus Rilpivirine on Vascular Function, Inflammation, and Oxidative Stress
NCT01585038
Anti-INFLammatory to Address Mood and Endothelial Dysfunction (INFLAMED)
NCT01625845
Exploring the Group Visit Model for Pediatric ADHD Management in the Medical Home
NCT02145793
Role of Exercise in Depression in Middle Aged and Older Adults
NCT01573728
Determining the Sensitivity of Sentinel Lymph Nodes Identified With Robotic Fluorescence Imaging
NCT01673022
Different Levels of Patient Education for Care of Ostomy Site
NCT02036268
Child Health Improvement Through Computer Automation (CHICA) Highlighting Study
NCT01583101
HealthyMe Online Weight Management Education/HealthyMe at Home
NCT02057952
Novel Use of (Oral) Ketotifen for the Treatment of Fibromyalgia: A Pilot Study
NCT01553318
Very Low Calorie Diet for Diabetic Kidney Disease
NCT01671969
Study of Sutent®/Sunitinib (SU11248) in Subjects With NF-1 Plexiform Neurofibromas
NCT01402817
HPV Vaccine Acceptability Among Young Men Who Have Sex With Men
NCT01535794
Evaluation of Oral Lipid Ingestion in Relation to Ovarian Androgen Secretion in Polycystic Ovary Syndrome (PCOS)
NCT01489319
Program ACTIVE II: Behavioral Depression Treatment for Type 2 Diabetes
NCT03371940
Effect of a Component of Fish Oil on Exercise-Induced Bronchoconstriction and Airway Inflammation in Asthma
NCT01504646
A Self-Guided Intervention to Promote Condom Use Among African American Males
NCT01536730
Evaluation of a New EUS-guided Needle (ProCore) Comparing to EUS-TCB Needle (Quick-Core)
NCT01768325
Cooperation of Insulin and GLP-1 on Myocardial Glucose Uptake
NCT01232946
Surgery Plus Celiac Nerve Block for Long-term Pancreatic Cancer Pain Control
NCT02002806
Effectiveness of Prolonged Use of IUD/Implant for Contraception
NCT02267616
Assessing the Effectiveness of a Weight Watchers-based Lifestyle Intervention for the Primary Prevention of Type 2 Diabetes
NCT02000024
The Impact of the Human Papilloma Virus in Pediatric Chronic Kidney Disease, Dialysis, and Transplant Patients
NCT00767897
PET/CT Assessment of Tumor Perfusion in Patients With Renal Cell Carcinoma
NCT01502228
Breast-Sparing Proton Therapy for Hodgkin's Disease
NCT02070393
Trial of a Computer-Based Presentation of Quantitative Information About Colorectal Cancer Screening
NCT01415479
Endotracheal Tube Versus Laryngeal Mask Airway for Esophagogastroduodenoscopy
NCT01936662
Antiplatelet Therapy Guided by Thrombelastography in Patients With Acute Coronary Syndromes (TEGCOR Study)
NCT01612884
Beating the Blues for Your Heart
NCT01605552
Individualized Dosing of Nifedipine For Tocolysis in Preterm Labor
NCT02090920
The CHICA Developmental Screening Study
NCT01351077
The Effect of N-Acetyl Cysteine on Cortical Erosion in Early Stage Schizophrenia
NCT01339858
PROGENI (Parkinson's Research: The Organized Genetics Initiative) Family Study of LRRK2 (Leucine-rich Repeat Kinase 2)
NCT01536821
Lenalidomide in Combination With a Fixed Dose of Sorafenib for the Treatment of Hepatocellular Carcinoma
NCT01348503
Narrow-Band Imaging Versus Standard White Light for the Detection of Serrated Lesions in the Proximal Colon
NCT01572428
Bariatric Surgery and the Kidney
NCT01410994
Effects of Switching Efavirenz to Raltegravir on Vascular Function and Bone Markers in HIV-infected Patients
NCT01270802
Comparative Research of Alzheimer's Disease Drugs
NCT01362686
Aqueous Suppressant Versus Aqueous Outflow on Ocular Blood Flow
NCT01308788
Effect of Dermal Rejuvenation on the UVB Response of Geriatric Skin
NCT02090894
A Comparator Study Evaluating Microbiological Resistance and Effects of Alternating Inhaled Antibiotic Therapies
NCT01319253
The Effects of Dexlansoprazole for the Treatment of Throat-Related Reflux
NCT01317472
Parent-son-provider Decision-making About HPV Vaccination
NCT01284374
A Study Inhibiting Telomerase to Reverse Trastuzumab Resistance in HER2+ Breast Cancer
NCT01265927
Study of Tasigna®/Nilotinib (AMN107) in Neurofibromatosis (NF1) Patients With Plexiform Neurofibromas
NCT01275586
Medication Reconciliation Technology to Improve Quality of Transitional Care
NCT01195051
Effect of a Component of Fish Oil on Exercise-Induced Bronchoconstriction and Airway Inflammation in Asthma
NCT01200446
Endoscopic Ultrasound (EUS) Features of Chronic Pancreatitis
NCT01442454
Preliminary Trial of the Effect of Glucocorticoid Receptor Antagonist on Borderline Personality Disorder (BPD)
NCT01212588
Remote Information Counseling for Elders
NCT01203995
Acamprosate in Youth With Fragile X Syndrome
NCT01300923
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 56 |
| Phase 2 | 70 |
| Phase 3 | 28 |
| Phase 4 | 76 |
Therapeutic Areas
What is open in the Indiana University pipeline
156 recruiting of 890 indexed (18% open); 561 completed (63%).
Phase mix: 104 late (III/IV) vs 126 early (I/II) (balanced across stages).
Top condition: Alzheimer Disease (11 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Indiana University: open-pipeline peers nationwide
Peers matched on 890 registered trials and 18% open enrollment, not the therapeutic-area sidebar.
Indiana University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 890 trials (± recruiting share)
- University of California, Los Angeles · 897 trials · 18% recruiting
- Hoffmann-La Roche · 909 trials · 8% recruiting
- Brigham and Women's Hospital · 937 trials · 15% recruiting
- University of Texas Southwestern Medical Center · 837 trials · 19% recruiting
Sponsors near 18% open enrollment (± trial volume)
- Edwards Lifesciences · 18% recruiting · 57 trials
- University of South Florida · 17% recruiting · 252 trials
- VA Office of Research and Development · 17% recruiting · 1,668 trials
- ConvaTec · 18% recruiting · 17 trials
Related
What to do with this Indiana University page
890 registered trials is a research-attention snapshot, not an endorsement of Indiana University or any single study.
- 156 of Indiana University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Alzheimer Disease is the condition Indiana University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Alzheimer Disease trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Indiana University pipeline card: 890 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.